All News #Library
Biotech
Alfasigma Reports 2025 Growth Led By Immunology Gastro Vascular
31 Mar 2026 //
BUSINESSWIRE
Alfasigma`s PBC treatment Ocaliva to face an FDA adcomm in September
09 Aug 2024 //
ENDPTS

Market Place
Sourcing Support